Since joining the Le Center Volunteer Ambulance in February, 2025 Zach Morrow has quickly proven himself to be one of the ...

Chugai Pharmaceutical Co., Ltd. announced that it obtained approval from the Ministry of Health, Labour and Welfare (MHLW) for the anti-cancer agent/humanized anti-PD-L1 monoclonal antibody Tecentriq ...

Cancer, the second leading cause of death worldwide, is more likely to respond to effective treatment if identified early before metastasizing, resulting in a greater probability of surviving. Science ...

Alveolar soft part sarcoma (ASPS) is a rare malignant soft tissue neoplasm characterized by distinctive histological features, indolent growth patterns and a propensity for metastasis. Recent ...

This study presents a rare case of acinar soft tissue sarcoma and provides a detailed analysis of its multi-parameter quantitative functional MRI (fMRI) characteristics. The patient, a 16-year-old ...

Recently these monocyte-derived alveolar macrophages, or Mo-AMs, were identified as key drivers of lung fibrosis disease progression. However, the mechanisms of their pro-fibrotic behavior and ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies to nearly two-thirds of SCLC cases at the time of diagnosis. A phase 3 ...

Basel, 3 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III IMforte study of Tecentriq® (atezolizumab) in combination with lurbinectedin (Zepzelca®) as ...

The Chicago Cubs have been waiting for a more relaxing stretch of the schedule, a chance to beat up on the rebuilds after playing a steady diet of contenders over the first quarter of the season.

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration ...